The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey

Basit Öğe Kaydı
dc.authorid0000-0001-9853-4753en_US
dc.authorid0000-0003-3570-3825en_US
dc.authorid0000-0003-4171-3368en_US
dc.authorid0000-0001-8645-2670en_US
dc.authorid0000-0003-1710-7018en_US
dc.authorid0000-0001-7737-4180en_US
dc.contributor.authorMalhan, Simten
dc.contributor.authorPay, Salih
dc.contributor.authorAtaman, Şebnem
dc.contributor.authorDalkılıç, Ediz
dc.contributor.authorDinç, Ayhan
dc.contributor.authorSoy, Mehmet
dc.date.accessioned2021-06-23T19:33:52Z
dc.date.available2021-06-23T19:33:52Z
dc.date.issued2012
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractObjectives To determine the direct and indirect costs due to rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients in Turkey. Methods An expert panel was convened to estimate the direct and indirect costs of care of patients with RA and AS in Turkey. The panel was composed of 22 experts chosen from all national tertiary care rheumatology units (n=53). To calculate direct costs, the medical management of RA and AS patients was estimated using "cost-of-illness" methodology. To measure indirect costs, the number of days of sick leave, the extent of disability, and the levels of early retirement and early death were also evaluated. Lost productivity costs were calculated using the "human capital approach", based on the minimum wage. Results The total annual direct costs were 2,917.03 Euros per RA patient and 3,565.9 Euros for each AS patient. The direct costs were thus substantial, but the indirect costs were much higher because of extensive morbidity and mortality rates. The total annual indirect costs were 7,058.99 Euros per RA patient and 6,989.81 for each AS patient. Thus, the total cost for each RA patient was 9,976.01 Euros and that for an AS patient 10,555.72 Euros, in Turkey. Conclusion From the societal perspective, both RA and AS have become burden in Turkey. The cost of lost productivity is higher than the medical cost. Another important conclusion is that indirect costs constitute 70% and 66% of total costs in patients with RA and AS, respectively.en_US
dc.identifier.endpage207en_US
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue2en_US
dc.identifier.pmid22546069en_US
dc.identifier.scopus2-s2.0-84863751510en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage202en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12491/7248
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84863751510&partnerID=40&md5=a7a3eaa5d35342acf28c948175e7fabc
dc.identifier.urihttps://www.clinexprheumatol.org/abstract.asp?a=4956
dc.identifier.volume30en_US
dc.identifier.wosWOS:000303905800010en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorSoy, Mehmet
dc.language.isoenen_US
dc.publisherClinical & Exper Rheumatologyen_US
dc.relation.ispartofClinical And Experimental Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRheumatoid Arthritisen_US
dc.subjectAnkylosing Spondylitisen_US
dc.subjectCosten_US
dc.subjectTurkeyen_US
dc.titleThe cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkeyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
simten-malhan.pdf
Boyut:
148.08 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu